About Molecular Response
Molecular Response was a Healthcare company based in San Diego (United States) founded in 2010, and was acquired by Bioduro in March 2018. It specializes in biospecimen storage and tumor biobanking services. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Biobanking and Biospecimen Storage. Its competitors include GenVault Corporation, iSpecimen and PrecisionMed; 2 of its 3 listed competitors have raised funding.
Company details
Molecular Response, founded in 2010 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, biobanking, and biospecimen storage. Specializes in biospecimen storage and tumor biobanking services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website molecularresponse.com
- Social Facebook
- Acquired by Bioduro (Mar 2018)
Investors in Molecular Response
Molecular Response has secured backing from 1 investor. Prominent investors backing the company include Bioduro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Integrated drug discovery and development services | 2005 | bioduro.com | San Diego, United States |
Investor details for Molecular Response
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molecular Response
2 dated milestones of Molecular Response across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Response is founded.
- Exit Acquired by Bioduro.
Competitors of Molecular Response
Molecular Response has 3 listed competitors in our database, 2 of them funded. They include GenVault Corporation, iSpecimen and PrecisionMed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | ||
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| precisionmed.com | 1996 | San Diego, United States | Human biological materials for research are supplied via a biorepository. |
Detailed competitors of Molecular Response
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Molecular Response (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecular Response
Complete news archive for Molecular Response
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Response
Molecular Response was founded in 2010.
Molecular Response is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Molecular Response, founded in 2010 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, biobanking, and biospecimen storage. Specializes in biospecimen storage and tumor biobanking services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Molecular Response's top competitors include iSpecimen, GenVault Corporation and PrecisionMed.
Molecular Response has 1 investor. Key investors include Bioduro.
Yes. Molecular Response was acquired by Bioduro in March 2018.